135 related articles for article (PubMed ID: 15305342)
1. Molecular analysis of WFDC1/ps20 gene in prostate cancer.
Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C
Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342
[TBL] [Abstract][Full Text] [Related]
2. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival.
McAlhany SJ; Ayala GE; Frolov A; Ressler SJ; Wheeler TM; Watson JE; Collins C; Rowley DR
Prostate; 2004 Oct; 61(2):182-91. PubMed ID: 15305341
[TBL] [Abstract][Full Text] [Related]
3. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
4. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
Gao AC; Lou W; Isaacs JT
Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237
[TBL] [Abstract][Full Text] [Related]
6. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prostate cancer-associated tumor antigen.
Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
[TBL] [Abstract][Full Text] [Related]
8. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
9. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
10. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
11. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue.
Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK
Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer expression profiling by cDNA sequencing analysis.
Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
[TBL] [Abstract][Full Text] [Related]
14. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.
Hickman OJ; Smith RA; Dasgupta P; Rao SN; Nayak S; Sreenivasan S; Vyakarnam A; Galustian C
Br J Cancer; 2016 May; 114(11):1235-42. PubMed ID: 27115470
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
16. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
Sun Y; Lin J; Katz AE; Fisher PB
Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032
[TBL] [Abstract][Full Text] [Related]
17. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
[TBL] [Abstract][Full Text] [Related]
18. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer.
Watson JE; Doggett NA; Albertson DG; Andaya A; Chinnaiyan A; van Dekken H; Ginzinger D; Haqq C; James K; Kamkar S; Kowbel D; Pinkel D; Schmitt L; Simko JP; Volik S; Weinberg VK; Paris PL; Collins C
Oncogene; 2004 Apr; 23(19):3487-94. PubMed ID: 15007382
[TBL] [Abstract][Full Text] [Related]
19. KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells.
Lu W; Zhou D; Glusman G; Utleg AG; White JT; Nelson PS; Vasicek TJ; Hood L; Lin B
Prostate; 2006 Jun; 66(9):936-44. PubMed ID: 16541416
[TBL] [Abstract][Full Text] [Related]
20. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]